Literature DB >> 26240075

Sex-specific predictors of improved walking with step-monitored, home-based exercise in peripheral artery disease.

Andrew W Gardner1, Donald E Parker2, Polly S Montgomery3.   

Abstract

The aim of this study was to determine whether baseline clinical characteristics and the duration and intensity of ambulation during our step-monitored home-based exercise program were predictive of changes in ambulatory outcomes at completion of the program in symptomatic patients with peripheral artery disease (PAD). Twenty-two men (ankle-brachial index (ABI) = 0.71 ± 0.19) and 24 women (ABI = 0.66 ± 0.23) completed the home exercise program, consisting of intermittent walking to mild-to-moderate claudication pain for 3 months. Ambulatory outcome measures were peak walking time (PWT) and claudication onset time (COT) during a treadmill test, and the distance recorded during a 6-minute walk distance test (6MWD). Men experienced significant increases (p<0.01) in COT, PWT, and 6MWD following the home exercise program, and women had significant increases in 6MWD (p<0.01) and PWT (p<0.05). In women, average exercise cadence during the home exercise sessions was the only predictor that entered the model for change in COT (p=0.082), and was the first predictor in the model for change in PWT (p=0.029) and 6MWD (p=0.006). In men, the ABI was the only predictor that entered the model for change in 6MWD (p=0.002), and ABI was a predictor along with metabolic syndrome in the model for change in COT (p=0.003). No variables entered the model for change in PWT. Faster ambulatory cadence during the step-monitored home-based exercise program may predict greater improvements in ambulatory function in women, whereas having less severe PAD and comorbid burden at baseline may predict greater improvements in ambulatory function in men. ClinicalTrials.gov Identifier: NCT00618670.
© The Author(s) 2015.

Entities:  

Keywords:  6-minute walk; claudication; home-based exercise; mobility; peripheral artery disease; walking; women

Mesh:

Year:  2015        PMID: 26240075      PMCID: PMC6004124          DOI: 10.1177/1358863X15596237

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  26 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  National health care costs of peripheral arterial disease in the Medicare population.

Authors:  Alan T Hirsch; Lacey Hartman; Robert J Town; Beth A Virnig
Journal:  Vasc Med       Date:  2008-08       Impact factor: 3.239

3.  Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.

Authors:  Teviah Sachs; Frank Pomposelli; Allen Hamdan; Mark Wyers; Marc Schermerhorn
Journal:  J Vasc Surg       Date:  2011-08-31       Impact factor: 4.268

4.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

5.  Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial.

Authors:  Mary M McDermott; Kiang Liu; Jack M Guralnik; Michael H Criqui; Bonnie Spring; Lu Tian; Kathryn Domanchuk; Luigi Ferrucci; Donald Lloyd-Jones; Melina Kibbe; Huimin Tao; Lihui Zhao; Yihua Liao; W Jack Rejeski
Journal:  JAMA       Date:  2013-07-03       Impact factor: 56.272

6.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

7.  Gender differences in daily ambulatory activity patterns in patients with intermittent claudication.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Aman Khurana; Raphael M Ritti-Dias; Steve M Blevins
Journal:  J Vasc Surg       Date:  2010-08-08       Impact factor: 4.268

8.  Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.

Authors:  Elizabeth M Mahoney; Kaijun Wang; Hong H Keo; Sue Duval; Kim G Smolderen; David J Cohen; Gabriel Steg; Deepak L Bhatt; Alan T Hirsch
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-12

9.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

Authors:  A W Gardner; E T Poehlman
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

10.  Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Steve M Blevins
Journal:  J Vasc Surg       Date:  2013-11-15       Impact factor: 4.268

View more
  4 in total

1.  Prediction of 6-minute walk performance in patients with peripheral artery disease.

Authors:  Xi Chen; Julie A Stoner; Polly S Montgomery; Ana I Casanegra; Federico Silva-Palacios; Sixia Chen; Amanda E Janitz; Andrew W Gardner
Journal:  J Vasc Surg       Date:  2017-06-21       Impact factor: 4.268

2.  Predictors of Improved Walking after a Supervised Walking Exercise Program in Men and Women with Peripheral Artery Disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery
Journal:  Int J Vasc Med       Date:  2016-12-25

3.  Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program.

Authors:  Ukachukwu Abaraogu; Elochukwu Ezenwankwo; Philippa Dall; Garry Tew; Wesley Stuart; Julie Brittenden; Chris Seenan
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

4.  Gender Differences in Outcomes Following a Pain-Free, Home-Based Exercise Program for Claudication.

Authors:  Roberto Manfredini; Nicola Lamberti; Fabio Manfredini; Sofia Straudi; Fabio Fabbian; Maria Aurora Rodriguez Borrego; Nino Basaglia; Juan Manuel Carmona Torres; Pablo Jesus Lopez Soto
Journal:  J Womens Health (Larchmt)       Date:  2018-09-15       Impact factor: 2.681

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.